Trials / Unknown

UnknownNCT01738074

Phase Three Clinical Trials of Trivalent Rotavirus Genetic Reassortment Vaccine

Status: Unknown
Phase: Phase 3
Study type: Interventional
Enrollment: 10,020 (actual)

Sponsor: Center for Disease Control and Prevention, Henan Province · Other Government
Sex: All
Age: 6 Weeks – 13 Weeks
Healthy volunteers: Accepted

Summary

Assessment and evaluation the rotavirus gastroenteritis prevention effect and severe rotavirus diarrhea reducing effectiveness of human body, which inoculate trivalent rotavirus genetic reassortment vaccine.

Conditions

Randomized
Double-blind
Placebo Control Design

Interventions

Type	Name	Description
BIOLOGICAL	trivalent rotavirus genetic reassortment vaccine
BIOLOGICAL	Placebo

Timeline

Start date: 2012-08-01
Primary completion: 2014-06-01
Completion: 2014-12-01
First posted: 2012-11-30
Last updated: 2012-11-30

Source: ClinicalTrials.gov record NCT01738074. Inclusion in this directory is not an endorsement.